EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.588
https://www.valueinhealthjournal.com/article/S1098-3015(24)00703-4/fulltext
Title :
EE289 Cost-Effectiveness Analysis of Blinatumomab for Advanced Acute Lymphoblastic Leukemia in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00703-4&doi=10.1016/j.jval.2024.03.588
First page :
Section Title :
Open access? :
No
Section Order :
10070